Healthy living is a goal for most. Yet, much too often individuals unknowingly engage in habits that hinder this goal.

Crinetics Pharma reports positive results from phase 2 trial of atumelnant in congenital adrenal hyperplasia: San Diego Monday, January 13, 2025, 16:30 Hrs [IST] Crinetics Pharmac ...

Pharmaceuticals announced positive topline results from an open-label, Phase 2 congenital adrenal hyperplasia, CAH, study of ...

Meaningful improvements in multiple clinical signs and symptoms of congenital adrenal hyperplasia (CAH), enhancing overall patient health. Positive safety profile with no severe or serious adverse ...

Substantial, Rapid and Sustained Statistically Significant Reductions of Key Biomarkers Achieved Across Doses, Including up to 80% Mean Reduction of Androstenedione Meaningful Improvements ...

(Nasdaq: CRNX) today announced positive topline results from an open-label, Phase 2 congenital ... on CAH signs and symptoms, including: Substantial reduction and normalization of testosterone in the ...

This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this ...

(Cancer vaccines are usually therapeutic, not preventative, unlike how we normally think of vaccines.) The world’s first trial for an mRNA vaccine against norovirus—the bug marked by intense vomiting ...

Obstructive sleep apnea may have some surprising signs and symptoms of the condition. You may expect it in someone who is overweight, snores loudly, and repeatedly wakes up gasping out of sleep.

Recognizing the symptoms of dehydration is important so you can work to replace lost fluids. Look out for symptoms like dry mouth, fatigue, dark-colored urine, and lightheadedness. Treating ...

When they do occur, STI symptoms in males can include discharge, bleeding, painful blisters, and more. Knowing the signs and symptoms of STIs can be important. Early treatment can help prevent ...

The U.S. Food and Drug Administration (FDA) has granted approval to crinecerfont, an innovative oral drug designed to treat classic congenital adrenal hyperplasia (CAH) in patients aged four years ...